Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-043046
Filing Date
2024-10-08
Accepted
2024-10-08 07:22:41
Documents
17
Effectiveness Date
2024-10-08

Document Format Files

Seq Description Document Type Size
1 S-8 ef20036399_s8.htm S-8 72912
2 EXHIBIT 5.1 ef20036399_ex5-1.htm EX-5.1 8631
3 EXHIBIT 23.1 ef20036399_ex23-1.htm EX-23.1 1759
4 EXHIBIT 23.2 ef20036399_ex23-2.htm EX-23.2 2298
5 exfilingfees.htm   iXBRL EX-FILING FEES 12569
6 image00001.jpg GRAPHIC 2465
  Complete submission text file 0001140361-24-043046.txt   228636

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4584
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-282537 | Film No.: 241359184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)